Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback